Skip to main content
TipRanks
Go Ultimate75% OFF

Oncopeptides AB (ONCO) Income Statement

11 Followers

Oncopeptides AB Income Statement

Last quarter (Q3 2026), Oncopeptides AB's total revenue was kr28.45M, an increase of 40.75% from the same quarter last year. In Q3, Oncopeptides AB's net income was kr-43.97M. See Oncopeptides AB’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
kr 71.12Mkr 31.65Mkr 35.22Mkr 8.36Mkr 118.30M
kr 59.00Mkr 28.98Mkr 36.30Mkr 8.35Mkr 65.17M
kr 287.93Mkr 312.48Mkr 289.75Mkr 357.70Mkr 1.49B
Depreciation and Amortizationkr 9.67Mkr 9.75Mkr 11.04Mkr 17.16Mkr 14.99M
kr -219.26Mkr -261.81Mkr -231.62Mkr -319.64Mkr -1.41B
kr -225.89Mkr -283.50Mkr -253.45Mkr -349.35Mkr -1.42B
kr -22.28Mkr -711.00Kkr 5.00Mkr 11.67Mkr -455.00K
kr -248.17Mkr -284.21Mkr -248.45Mkr -337.68Mkr -1.42B
kr -249.59Mkr -284.61Mkr -249.11Mkr -337.95Mkr -1.43B
Per Share Metrics
Basic EPSkr -1.10kr -1.71kr -1.96kr -4.11kr -19.00
Diluted EPSkr -1.10kr -1.71kr -1.96kr -4.11kr -19.00
Weighted Average Shares Outstanding226.90M166.44M126.84M82.32M75.29M
Weighted Average Shares Outstanding (Diluted)226.90M166.44M126.84M82.32M75.29M

Currency in SEK

Oncopeptides AB Earnings and Revenue History

-2B-1B01B-4500 %-3000 %-1500 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin